Third-party lab testing: 19 independent Janoshik assays on file, covering 18 substances, median measured purity 99.8%, most recent test 2026-04-09.
USRoids is listed as active. Identified through Janoshik third-party lab testing: 19 assays on file, most recent 2026-04-09.
| Substance | Measured purity | Test date |
|---|---|---|
| Sample 12 | not reported | 2026-04-09 |
| Sample 6 | not reported | 2026-04-08 |
| Sample 4 | not reported | 2026-04-08 |
| 8 | not reported | 2026-04-02 |
| 5 | not reported | 2026-04-02 |
| 22 | not reported | 2026-04-01 |
| 21 | not reported | 2026-04-01 |
| 20 | not reported | 2026-04-01 |
| 17 | not reported | 2026-04-01 |
| 10 | not reported | 2026-04-01 |
| 9 | not reported | 2026-04-01 |
| 7 | not reported | 2026-04-01 |
None of these 12 assays carry a purity number on the certificate. They confirm the substance was submitted and tested, which is not the same as a measured result and not the same as a failure.
| Status | Active |
|---|---|
| Independent assays on file | 19 |
| Median measured purity | 99.8% |
| Certificates of analysis | Vendor states COAs are available |
| Vendor type | Research-use supplier |
| Last tested | 2026-04-09 |
These details were read from USRoids's own website on 2026-08-16. Pages consulted:
USRoids is listed as active and we hold 19 independent Janoshik assays on file, median measured purity 99.8%. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. We hold 19 third-party Janoshik assays for USRoids, covering 18 substances, with a median measured purity of 99.8%. The most recent is dated 2026-04-09.
Tested substances: SEMAGLUTIDE 30mg, TIRZEPATIDE 30mg, RETATRUTIDE 30mg.
Similar vendors: biopharmaservice, Qing Li Peptide, Cocer Peptides, Eros Peptides, Reta-Peptide, Zztai Peptide, Henan Sahe Peptide, Yiwu Aozuo Trading Firm.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Uther Peptides Review, utherpeptide Review, uwa-biotech Peptides Review.